MedTrace Logo

Improving Cardiac Rehabilitation Participation in Women and Men

NCT00336830 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1035

Last updated 2014-03-27

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of a pre-discharge written personal endorsement to the patient by the patient's attending cardiologist or cardiac surgeon (MD endorsement) to take part in the Cardiac Rehabilitation and Secondary Prevention (CR) program, in addition to the standard CR referral, compared to the standard CR referral alone, on CR program enrollment within 2 months of index hospital discharge following admission for myocardial infarction, unstable angina, coronary angioplasty, or coronary artery bypass.

Conditions

Interventions

BEHAVIORAL

MD-endorsed Cardiac Rehabilitation referral

Note to patient with general description of the Cardiac Rehabilitation program with signature and strong recommendation from attending physician.

BEHAVIORAL

Standard Cardiac Rehabilitation referral

Note to patient with general description of the Cardiac Rehabilitation program without signature or recommendation from attending physician.

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • AstraZeneca

    collaborator INDUSTRY

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • Neville Suskin, MBChB, MSc · University of Western Ontario & London Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2007-06-30
Completion
2009-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00336830 on ClinicalTrials.gov